Christoph Korpus

Seminars

Tuesday 9th September 2025
Delivering a New Generation of Antibody-Drug Conjugates & Antibody Cancer Therapeutics
3:00 pm
  • Advancing clinical stage assets against validated cancer targets and promising preclinical pipeline
  • Delivering diversity, selectivity and novel mechanisms of action
  • Leveraging unique fully integrated, in-house discovery, development and manufacturing